Research Article

The Safety and Efficacy of Lansoprazole plus Metoclopramide among Neonates with Gastroesophageal Reflux Disease Resistant to Conservative Therapy and Monotherapy: A Clinical Trial

Table 5

The changes of GERD-related scoring of clinical manifestations and percentage of response rate one week and one month after intervention.

The mean response rateRanitidine plus metoclopramide (group A) Lansoprazole plus metoclopramide (group B) Intergroup value

Preintervention clinical manifestation scoring, 0.263
Overall clinical manifestation scoring, one week after intervention, 0.018
Percentage of response rate one week after intervention,
Overall clinical manifestation scoring, one month after intervention, 0.003
Percentage of response rate, one month after intervention,
Intragroup value≤0.001≤0.001≤0.001

Intragroup value means value between pre- and postintervention in each group; intergroup value means value between two groups of intervention.